Previous close | 25.30 |
Open | 25.25 |
Bid | 25.94 x 400 |
Ask | 26.01 x 400 |
Day's range | 24.99 - 26.12 |
52-week range | 22.36 - 50.78 |
Volume | |
Avg. volume | 1,019,744 |
Market cap | 2.048B |
Beta (5Y monthly) | 1.17 |
PE ratio (TTM) | 49.98 |
EPS (TTM) | 0.52 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 33.63 |
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q1 2024 Earnings Call Transcript May 6, 2024 Integra LifeSciences Holdings Corporation misses on earnings expectations. Reported EPS is $-0.04221 EPS, expectations were $0.55. IART isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, […]
Despite mixed financial results, Integra Lifesciences outlines strategic moves and robust international growth in the first quarter of 2024.